When a patient is admitted to the emergency department with symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operative outcomes requires rapid and accurate assessment of chest pain at the point of care, as well as coordination with the laboratory to ensure quality. Having high-sensitivity point-of-care troponin testing, which produces accurate results in just 8 minutes, could transform healthcare delivery for millions of people each year, improving ED performance, reducing stress and strain on intensive care physicians and helping to optimize the use of time and resources in busy laboratories.<\/p>\n
Features and Benefits:<\/p>\n
The easy-to-use Atellica\u00ae VTLi Immunoassay Analyzer, powered by Magnotech\u00ae technology, produces highly sensitive, accurate and clinically viable troponin I results directly into the hands of those who need it most.<\/p>\n
The Atellica\u00ae VTLi System speeds up the evaluation of chest pain, allowing for a faster decision on the fate of patients who do not have a myocardial infarction and rapid treatment for those who do.
\nThe Atellica\u00ae VTLi System offers hs-cTnl testing right at the point of care. Results are available in just minutes to physicians and laboratory collaborators.
\nThe Atellica\u00ae VTLi System will help transform the chest pain assessment process to benefit patients, clinicians and operational workflow.<\/p>\n","protected":false},"excerpt":{"rendered":"
When a patient is admitted to the emergency department with symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operative outcomes requires rapid and accurate assessment of chest pain at the point of care, as well as coordination with the laboratory to ensure quality.<\/p>\n